Concepedia

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor–transgenic mice

Georg Schett, Kurt Redlich, Silvia Hayer, Jochen Zwerina, Brad Bolon, Colin R. Dunstan, Birgit Görtz, Andreas Schulz, Helga Bergmeister, G Steiner,

Arthritis & Rheumatism · 2003 · 148 citations · 47 references

DOI

Abstract

OPG may represent a potent tool for preventing generalized loss of bone mass in chronic inflammatory disorders, especially RA.

References

47

Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density

W. Scott Simonet, Dave Lacey, Colin R. Dunstan et al. · Cell · 1997 · 5.1K citations · Full text

, , +13

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

A. M. Parfitt, Marc K. Drezner, Francis H. Glorieux et al. · Journal of Bone and Mineral Research · 1987 · 5K citations

, , +20

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Hisataka Yasuda, Nobuyuki Shima, N. Nakagawa et al. · Proceedings of the National Academy of Sciences · 1998 · 4.2K citations · Full text

, , +14

Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units

A. M. Parfitt, M. K. Drezner, Francis H. Glorieux et al. · Journal of Bone and Mineral Research · 1987 · 3.3K citations

, , +6

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair et al. · New England Journal of Medicine · 2000 · 3K citations · Full text